Serum bone Gla protein as an indicator of parathyroidectomy in patients with secondary hyperparathyroidism
- 1 May 1990
- journal article
- Published by Wiley in World Journal of Surgery
- Vol. 14 (3) , 431-435
- https://doi.org/10.1007/bf01658548
Abstract
Bone Gla protein (BGP) is a vitamin K-dependent protein which is a marker of bone turnover. To determine whether serum BGP is a useful indicator for parathyroidectomy in patients with secondary hyperparathyroidism, we measured serum BGP levels. Thirty-seven patients with secondary hyperparathyroidism who were followed up for more than 1 year after parathyroidectomy were studied. All patients underwent total parathyroidectomy and autotransplantation. Controls were 46 patients who were treated by chronic hemodialysis for more than 3 years. Serum BGP levels (normal: (p<0.001). Patients with a high BGP level had severe bone and joint pain. Serum BGP in patients with parathyroidectomy was significantly correlated with serum alkaline phosphatase and mPTH (p<0.001 for both). The total weight of resected parathyroid tumors was 2,152±1,368 mg, and tumor weights ranged from 200 mg to 5,600 mg. There was a highly significant correlation between BGP level and tumor weight (r=0.656,p<0.001). The 2 patients who showed BGP levels below 10 ng/ml had tumor weights of only 470 mg and 240 mg, respectively, and revealed no improvement of pain postoperatively, although their mPTH levels were increased. These results suggested that BGP measurement is a sensitive method for detecting increased bone turnover and is possibly useful as an indicator for parathyroidectomy in patients with secondary hyperparathyroidism. La protéine BGP (bone Gla protein) est une protéine dépendante de la vitamine K, marqueur de renouvellement osseux. Pour savoir si la BGP était un indicateur utile de parathyroïdectomie chez les patients ayant une hyperparathyroïdie secondaire (HP II), nous avons mesuré les niveaux sériques de BGP. Trente-sept patients ayant une HP II suivis un an au moins après leur parathyroïdectomie ont été étudiés. Tous les patients ont eu une parathyroïdectomie totale avec réimplantation. Nous avons également mesuré la BGP chez 46 patients hémodialysés chroniques depuis au moins 3 ans comme témoins. Le taux sérique de BGP (normal: ppr=0.656,pppp<0.001). Los 2...Keywords
This publication has 20 references indexed in Scilit:
- Bone histomorphometry and serum bone gla‐protein in the diagnosis of primary hyperparathyroidismWorld Journal of Surgery, 1986
- Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-upKidney International, 1985
- Treatment of HypercalciuriaNew England Journal of Medicine, 1984
- Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss.Journal of Clinical Investigation, 1983
- Measurements of γ-carboxyglutamate and circulating osteocalcin in normal children and adultsClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- Changes in plasma bone GLA protein during treatment of bone diseaseCalcified Tissue International, 1982
- New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.Journal of Clinical Investigation, 1980
- Carboxylated Calcium-Binding Proteins and Vitamin KNew England Journal of Medicine, 1980
- Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma.Proceedings of the National Academy of Sciences, 1980